HARRY HUGHES, Governor
2961
(1) ANY SERIOUS ILLNESS, DISABILITY, OR IMPAIRMENT OF
MENTAL, EMOTIONAL, BEHAVIORAL, OR PHYSICAL FUNCTIONING OR
DEVELOPMENT, THE FIRST MANIFESTATION OF WHICH APPEARS WITHIN 7
DAYS AFTER THE DATE OF ADMINISTRATION OF PERTUSSIS VACCINE AND
WHICH, MORE LIKELY THAN NOT, IS CAUSED BY OR IS SIGNIFICANTLY
CONTRIBUTED TO BY THE PERTUSSIS VACCINE; AND FOR WHICH THERE__IS
REASONABLE SCIENTIFIC OR MEDICAL EVIDENCE THAT PERTUSSIS VACCINE
CAUSES, OR SIGNIFICANTLY CONTRIBUTES TO, SUCH EFFECT; AND
(2) ANY OTHER REACTION, WHICH THE DEPARTMENT, AFTER
CONSULTATION WITH HEALTH CARE PROVIDERS THE MEDICAL AND
CHIRURGICAL FACULTY OF MARYLAND, DETERMINES BY REGULATION
GUIDELINE IS A BASIS FOR NOT CONTINUING WITH PERTUSSIS VACCINE
ADMINISTRATION.
18-329.
(A) (1) PRIOR TO THE ADMINISTRATION OF PERTUSSIS VACCINE,
THE HEALTH CARE PROVIDER SHALL PROVIDE TO THE INDIVIDUAL'S PARENT
OR GUARDIAN WRITTEN INFORMATION SATISFYING THE REQUIREMENTS OF
THIS SUBSECTION, AND BY APPROPRIATE INQUIRIES ATTEMPT TO ELICIT
THE INFORMATION NECESSARY TO MAKE THE DETERMINATIONS REQUIRED BY
§ 18-332(B) OF THIS SUBTITLE.
(2) THE INFORMATION REQUIRED UNDER § 4-204(C) OF THIS
ARTICLE, AS TO PERTUSSIS VACCINE, AND UNDER PARAGRAPH (1) OF THIS
SUBSECTION SHALL INCLUDE:
(I) THE FREQUENCY, SEVERITY, AND POTENTIAL
LONG-TERM EFFECTS OF PERTUSSIS;
(II) POSSIBLE ADVERSE REACTIONS TO PERTUSSIS
VACCINE WHICH, IF THEY OCCUR, SHOULD BE BROUGHT TO THE IMMEDIATE
ATTENTION OF THE HEALTH CARE PROVIDER;
(III) A FORM LISTING SYMPTOMS TO BE MONITORED
AND CONTAINING PLACES WHERE INFORMATION CAN BE RECORDED TO ASSIST
IN REPORTING TO THE HEALTH CARE PROVIDER, LOCAL HEALTH OFFICER,
AND THE DEPARTMENT;
(IV) MEASURES PARENTS SHOULD TAKE TO REDUCE THE
RISK OF, OR TO RESPOND TO, ANY MAJOR ADVERSE REACTION;
(V) EARLY WARNING SIGNS OR SYMPTOMS TO WHICH
PARENTS SHOULD BE ALERT AS POSSIBLE PRECURSORS TO A MAJOR ADVERSE
REACTION;
(VI) WHEN AND TO WHOM PARENTS SHOULD REPORT ANY
MAJOR ADVERSE REACTION; AND
(VII) A SUMMARY OF THE IMMUNIZATION
REQUIREMENTS RELATING TO PERTUSSIS VACCINE ADOPTED UNDER §
7-402(A) OF THE EDUCATION ARTICLE . , INCLUDING THOSE RELATED TO
PERTUSSIS VACCINE; AND
|